Wesbanco Bank Inc Atri Cure, Inc. Transaction History

Wesbanco Bank Inc

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 Apr 23, 2024	BUY	$28.21 - $37.78 $437,960 - $586,534	15,525 New	15,525 $472,000
Q3 2023 Dec 11, 2023	BUY	$41.12 - $57.73 $370,080 - $519,570	9,000 Added 137.93%	15,525 $679,000
Q4 2022 Jan 18, 2023	BUY	$33.48 - $47.45 $218,456 - $309,611	6,525 New	6,525 $290,000
Q4 2021 Feb 02, 2022	SELL	$63.4 - $87.14 $223,485 - $307,168	-3,525 Reduced 35.07%	6,525 $454,000
Q2 2021 Aug 09, 2021	SELL	$64.13 - $80.18 $192,390 - $240,540	-3,000 Reduced 22.99%	10,050 $797,000
Q1 2021 May 06, 2021	SELL	$53.79 - $66.98 $170,890 - $212,795	-3,177 Reduced 19.58%	13,050 $855,000
Q4 2019 Feb 13, 2020	BUY	$24.06 - $32.51 $390,421 - $527,539	16,227 New	16,227 $528,000

212

49.7M

12K

7.2K

Ticker ATRC
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 46,424,700
Market Cap $1.4B
Description
AtriCure, Inc. develops, manufactures, and sells devices for the surgical ablation of cardiac tissue and systems, and intercostal nerves to medical centers in the United States, Europe, Asia, and internationally. The company offers Isolator Synergy Clamps, a single-use disposable radio frequency products; multifunctional pens and linear ablation...

Get notified when there are updates to the investment portfolio of Wesbanco Bank Inc, based on Form 13F filings with the SEC.

Stay updated on Wesbanco Bank Inc with notifications on news.